The company recorded $925m in revenue in the second quarter of 2020, exceeding the top end of its previous guidance, and expects to return to growth by the end of the year.
The volume of transcatheter aortic valve replacement (TAVR) procedures performed by hospitals around the world is gradually recovering to its pre-pandemic level, according to market leader Edwards Lifesciences Corp.
In the second quarter of 2020, revenue from SAPIEN devices declined 11.5% year-over-year to $594.3m. Sales of TAVR devices were especially depressed in April as hospitals around the world began...
TRiCares presented data from the first-in-human study for its tricuspid valve replacement system – Topaz – at EuroPCR 2025 on 22 May.
The US’ 90-day suspension of higher “reciprocal tariffs” will expire on 9 July, raising fears that the 31% tariff rate on Swiss medtech and other goods exported to the US might make a comeback. While the tariff situation changes on an almost daily basis, medtechs should forearm for any eventually, say local business organizations.
Guardant Health introduces a new germline panel test to help guide cancer treatment, assess the risk of secondary cancers in patients and identify family members at risk of cancer.
